Alternative Dosing Strategy for Anti-HIV Drugs
NCT00059384
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
66
Enrollment
NIH
Sponsor class
Conditions
HIV Infections
Interventions
BEHAVIORAL:
Concentration-controlled therapy
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)